Mitigating Effect of Nitrates (Monizol) on Pharmacodynamic Shifts in the Cardiovascular System Caused by Radioprotector Indralin


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

We studied the effect of radioprotector indralin (B-190) alone or in combination with monizol on BP and HR in rabbits, reduction of blood supply and spleen weight in rats and (CBA×C57Bl/6)F1 hybrids mice, and on blood loss from a wound on tip of the tail in mice. Being an α1-adrenomimetic, indralin caused hypertensive reaction with the development of bradycardia, reduced blood supply and spleen weight, and sharply reduced blood loss from the wound. Monizol as nitrate reduced BP without affecting HR and reduced blood loss from the wound. Monizol administered prior to indralin eliminated radioprotector-induced hypertensive reaction, reduced bradycardia by more than 2 times, and attenuated the effect of indralin on spleen weight and blood loss from the wound by 1.6-1.8 times. Monizol administered after indralin had no effect on shifts in peripheral blood supply caused by the radioprotector.

Sobre autores

M. Vasin

State Research Centre F. M. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency

Autor responsável pela correspondência
Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

T. Gan’shina

V. V. Zakusov Research Institute of Pharmacology

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

R. Mirzoyan

V. V. Zakusov Research Institute of Pharmacology

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

L. Semenova

State Research Centre F. M. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

L. Koroleva

State Research Centre F. M. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

R. Afanas’ev

State Research Centre F. M. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow

I. Ushakov

State Research Centre F. M. Burnazyan Federal Medical Biophysical Center, Federal Medical-Biological Agency

Email: mikhail-v-vasin@yandex.ru
Rússia, Moscow


Declaração de direitos autorais © Springer Science+Business Media, LLC, part of Springer Nature, 2018

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies